Urologic Neoplasms  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Urologic Neoplasms
NCT00589017: Tamoxifen in Treating Patients With Metastatic Bladder Cancer That Did Not Respond to Previous Chemotherapy

Recruiting
2
75
US, Europe
tamoxifen citrate, immunohistochemistry staining method, laboratory biomarker analysis
Baylor College of Medicine
Bladder Cancer
07/10
 
HYBRID, NCT01810757: Study of Weekly Radiotherapy for Bladder Cancer

Active, not recruiting
2
64
Europe
Standard planning radiotherapy, Adaptive planning radiotherapy
Institute of Cancer Research, United Kingdom, Cancer Research UK
Bladder Cancer
07/17
01/25

Download Options